Drug: Vincristine Injury: Disease progression Quarter: 2016Q3
Total Records: 45 Number of Pages: 3
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126227321 | VINCRISTINE | Disease progression | BAXTER | 0.00 | 0 | 20160804 | KR | |
126227341 | VINCRISTINE | Disease progression | BAXTER | 0.00 | 0 | 20160804 | KR | |
126227351 | VINCRISTINE | Disease progression | BAXTER | 0.00 | 0 | 20160804 | KR | |
126227391 | VINCRISTINE | Disease progression | BAXTER | 0.00 | 0 | 20160804 | KR | |
126227401 | VINCRISTINE | Disease progression | BAXTER | 0.00 | 0 | 20160804 | KR | |
126227451 | VINCRISTINE | Disease progression | BAXTER | 0.00 | 0 | 20160804 | KR | |
126227461 | VINCRISTINE | Disease progression | BAXTER | 0.00 | 0 | 20160804 | KR | |
126291401 | VINCRISTINE | Disease progression | 71.00 YR | M | 79 KG | 20160805 | COUNTRY NOT SPECIFIED | |
126296132 | VINCRISTINE | Disease progression | TEVA | 0.00 | F | 0 | 20160825 | GB |
126487362 | VINCRISTINE | Disease progression | JANSSEN | 0.00 | F | 0 | 20160816 | GB |
126532702 | VINCRISTINE | Disease progression | BAUSCH AND LOMB | 0.00 | F | 0 | 20160816 | GB |
126602891 | VINCRISTINE | Disease progression | FRESENIUS KABI | 0.00 | F | 0 | 20160817 | GB |
126748771 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160823 | CN | |
126754753 | VINCRISTINE | Disease progression | ACCORD | 0.00 | F | 0 | 20160906 | GB |
126789751 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160824 | US | |
126838201 | VINCRISTINE | Disease progression | CONCORDIA | 0.00 | M | 0 | 20160825 | GB |
126870932 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160919 | DE | |
126916221 | VINCRISTINE | Disease progression | BAUSCH AND LOMB | 0.00 | M | 0 | 20160826 | GB |
126930511 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160829 | US | |
126967242 | VINCRISTINE | Disease progression | ACCORD | 62.00 YR | F | 0 | 20160901 | GB |
Total Records: 45 Number of Pages: 3